UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Sabal Trust CO

Sabal Trust CO raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 62,252 shares of the healthcare conglomerate’s stock after buying an additional 326 shares during the quarter. UnitedHealth Group makes up about 1.8% of Sabal Trust CO’s investment portfolio, making the stock its 16th largest holding. Sabal Trust CO’s holdings in UnitedHealth Group were worth $32,604,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG raised its position in shares of UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares in the last quarter. Impax Asset Management Group plc bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $700,000. Finally, Exchange Capital Management Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $426,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on UNH. Raymond James Financial downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Truist Financial reissued a “buy” rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a report on Friday, June 20th. Finally, Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target on the stock. in a report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $415.57.

Insiders Place Their Bets

In other news, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $302.19 on Thursday. The stock has a market cap of $274.13 billion, a P/E ratio of 12.65, a P/E/G ratio of 1.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50 day simple moving average of $342.22 and a 200 day simple moving average of $458.07. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the business posted $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.93%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.